However, in gastric cancer, SFRP4 expression is upregulated by the reduced methylation, and high expression of SFRP4 could promote cell viability and proliferation and inhibit apoptosis, as well as activate the Wnt pathway and promote tumor progression (Busuttil et al., 2021). This evidence concerns the gene SFRP4 and gastric cancer.